Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.58 is 75% below its 5-year average of 2.32, near the low end of its 5-year range (0.35–10.79).
As of the fiscal period ended Tuesday, June 30, 2026. 70.23% below its 12-month average of 1.94.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.58.
CURRENT RATIO
0.58
CURRENT RATIO AVG TTM
1.94
CURRENT RATIO AVG 3Y
2.38
CURRENT RATIO AVG 5Y
2.32
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-70.23%
CURRENT VS 3Y AVG
-75.67%
CURRENT VS 5Y AVG
-75.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-84.61%
vs the sector median at left
Market Cap
$1.83M
Current Ratio
0.03
TTM Avg
0.09
3Y Avg
0.05
5Y Avg
0.04
Market Cap
$1.81M
Current Ratio
0.77
TTM Avg
3.21
3Y Avg
3.22
5Y Avg
4.15
Market Cap
$1.88M
Current Ratio
1.97
TTM Avg
4.42
3Y Avg
2.96
5Y Avg
3.81
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenon Medical, Inc. (TNON) | $1.84M | 0.58 | 1.94 | 2.38 | 2.32 |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | 3.31 | 3.50 | 3.45 | 5.38 |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | 0.03 | 0.09 | 0.05 | 0.04 |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | 0.77 | 3.21 | 3.22 | 4.15 |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | 1.97 | 4.42 | 2.96 | 3.81 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 4.85 | 5.04 | 6.52 | 9.62 |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | 5.36 | 7.82 | 13.02 | 13.90 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | 1.54 | 2.65 | 3.41 | 4.73 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 0.21 | 0.87 | 0.72 | 1.52 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | 7.70 | 0.13 | 0.13 | 0.13 |
Current Ratio
0.58
Quick Ratio
0.48
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.58 |
| 2026-03-31 | 1.03 |
| 2025-12-31 | 2.11 |
| 2025-09-30 | 2.15 |
| 2025-06-30 | 3.86 |
| 2025-03-31 | 5.46 |
| 2024-12-31 | 4.39 |
| 2024-09-30 | 3.52 |
| 2024-06-30 | 1.20 |
| 2024-03-31 | 2.63 |
| 2023-12-31 | 1.24 |
| 2023-09-30 | 1.61 |
| 2023-06-30 | 1.15 |
| 2023-03-31 | 2.12 |
| 2022-12-31 | 3.69 |
| 2022-09-30 | 10.79 |
| 2022-06-30 | 7.54 |
| 2022-03-31 | 0.35 |
| 2021-12-31 | 0.50 |
| 2021-09-30 | 0.65 |
| 2021-06-30 | 0.68 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.20 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
